Embecta Corp. (NASDAQ:EMBC) Stock Holdings Trimmed by Covestor Ltd

Covestor Ltd lowered its holdings in shares of Embecta Corp. (NASDAQ:EMBC) by 24.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,263 shares of the company’s stock after selling 717 shares during the period. Covestor Ltd’s holdings in Embecta were worth $32,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Commerzbank Aktiengesellschaft FI bought a new stake in Embecta during the 3rd quarter valued at $470,000. Copeland Capital Management LLC bought a new stake in Embecta during the 3rd quarter valued at $43,000. Inspire Advisors LLC raised its stake in Embecta by 108.3% during the 3rd quarter. Inspire Advisors LLC now owns 31,169 shares of the company’s stock valued at $439,000 after acquiring an additional 16,207 shares in the last quarter. Inspire Investing LLC bought a new stake in Embecta during the 3rd quarter valued at $413,000. Finally, CWM LLC increased its position in shares of Embecta by 11.3% during the 3rd quarter. CWM LLC now owns 10,102 shares of the company’s stock valued at $142,000 after purchasing an additional 1,023 shares during the period. Institutional investors own 93.83% of the company’s stock.

Embecta Stock Performance

Shares of EMBC stock opened at $14.62 on Friday. Embecta Corp. has a 1 year low of $9.93 and a 1 year high of $19.79. The stock has a market cap of $843.60 million, a PE ratio of 12.18 and a beta of 0.97. The business’s fifty day moving average is $14.55 and its 200-day moving average is $13.86.

About Embecta

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.